{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:56:29Z","timestamp":1781805389891,"version":"3.54.5"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00004","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T05:54:31Z","timestamp":1581400471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression"],"prefix":"10.3389","volume":"10","author":[{"given":"Junying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lengxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2018.02776","article-title":"The yin and yang of myeloid derived suppressor cells","volume":"9","author":"Budhwar","year":"2018","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.3748\/wjg.v21.i36.10327","article-title":"Transarterial chemoembolization in hepatocellular carcinoma treatment: barcelona clinic liver cancer staging system","volume":"21","author":"Han","year":"2015","journal-title":"World J Gastroenterl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jhbp.422","article-title":"Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-\u03b2","volume":"24","author":"Sakisaka","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.21037\/jgo.2018.06.01","article-title":"Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions","volume":"9","author":"Lin","year":"2018","journal-title":"J Gastrointest Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ijc.29428","article-title":"Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma","volume":"137","author":"Jeong","year":"2015","journal-title":"Int J Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3389\/fimmu.2018.02030","article-title":"Radiation and local anti-CD40 generate an effective in situ vaccine in preclinical models of pancreatic cancer","volume":"9","author":"Yasmin-Karim","year":"2018","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fonc.2012.00191","article-title":"Radiation-induced effects and the immune system in cancer","volume":"2","author":"Kaur","year":"2012","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1358\/dot.2019.55.2.2903217","article-title":"Abscopal effects observed in cancer radiation therapy and oncolytic virotherapy: an overview","volume":"55","author":"Romano","year":"2019","journal-title":"Drugs Today"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3389\/fimmu.2017.01476","article-title":"Local high-dose radiotherapy induces systemic immunomodulating effects of potential therapeutic relevance in oligometastatic breast cancer","volume":"8","author":"Muraro","year":"2017","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Silvia chiara formenti and sandra demaria. Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Trends Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2017.09.017","article-title":"Critical features and challenges associated with imaging in patients undergoing cancer immunotherapy","volume":"120","author":"Solinas","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semradonc.2014.07.008","article-title":"Myeloid-derived cells in tumors: effects of radiation","volume":"25","author":"Vatner","year":"2015","journal-title":"Semin Radiat Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-12-3981","article-title":"CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer","volume":"73","author":"Xu","year":"2013","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e39295","DOI":"10.1371\/journal.pone.0039295","article-title":"Expression of NF-\u03baB p50 in tumor stroma limits the control of tumors by radiation therapy","volume":"7","author":"Crittenden","year":"2012","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2018.01.071","article-title":"Targeting myeloid-derived suppressor cells and programmed death ligand 1 confers therapeutic advantage of ablative hypofractionated radiation therapy compared with conventional fractionated radiation therapy","volume":"101","author":"Lan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1007\/s13277-016-4916-2","article-title":"The clinical and prognostic significance of CD14(+)HLA-DR(\u2212\/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7521701","DOI":"10.1155\/2017\/7521701","article-title":"A Novel CD48-based analysis of sepsis-induced mouse myeloid-derived suppressor cell compartments","volume":"2017","author":"Bei","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1450713","DOI":"10.1080\/2162402X.2018.1450713","article-title":"\u03b4-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8+ T cell activation","volume":"7","author":"Huang","year":"2018","journal-title":"Oncoimmunology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.3748\/wjg.v24.i32.3583","article-title":"Prognostic significance of tumor immune microenvironment and immunotherapy: novel insights and future perspectives in gastric cancer","volume":"24","author":"Laz\u0103r","year":"2018","journal-title":"World J Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.acr.2015.04.002","article-title":"Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment","volume":"128","author":"Parker","year":"2015","journal-title":"Adv Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.3389\/fimmu.2018.02250","article-title":"Diamonds in the rough: harnessing tumor-associated myeloid cells for cancer therapy","volume":"9","author":"Clappaert","year":"2018","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s40425-019-0634-9","article-title":"Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination","volume":"7","author":"Mathieu","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0171559","DOI":"10.1371\/journal.pone.0171559","article-title":"A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?","volume":"12","author":"Marconi","year":"2017","journal-title":"PLoS ONE"},{"key":"B35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00335-018-9777-0","article-title":"Radiation, inflammation and the immune response in cancer","volume":"29","author":"McKelvey","year":"2018","journal-title":"Mamm Genome."},{"key":"B36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fonc.2019.00215","article-title":"Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: novel strategies for preventing the tumor-protective effects of radiotherapy","volume":"9","author":"Ostrand-Rosenberg","year":"2019","journal-title":"Front. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/cr.2012.178","article-title":"A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells","volume":"23","author":"Zhang","year":"2013","journal-title":"Cell Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1158\/1078-0432.CCR-14-2742","article-title":"Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy","volume":"21","author":"Chen","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nature13638","article-title":"Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer","volume":"515","author":"Di Mitri","year":"2014","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3892\/or.2018.6254","article-title":"CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver","volume":"39","author":"Benedicto","year":"2018","journal-title":"Oncol Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1158\/0008-5472.CAN-13-1545","article-title":"Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer","volume":"74","author":"Alizadeh","year":"2014","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"50277","DOI":"10.18632\/oncotarget.10364","article-title":"Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment","volume":"7","author":"van Hooren","year":"2016","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jtho.2018.03.032","article-title":"Bevacizumab reduces S100A9-positive mdscs linked to intracranial control in patients with EGFR-mutant lung adenocarcinoma","volume":"13","author":"Feng","year":"2018","journal-title":"J Thorac Oncol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T05:54:33Z","timestamp":1581400473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":47,"alternative-id":["10.3389\/fonc.2020.00004"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00004","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"article-number":"4"}}